Assessment of Safety, Immunogenicity and Efficacy of R21/Matrix-M1 Malaria Vaccine in Healthy WOCBP in Mali

Conditions: Healthy Women of Child Bearing Potential Interventions: Biological: R21/Matrix-M1; Biological: Saline and R21/Matrix-M1; Other: Sterile isotonic (0.9%) normal saline Sponsors: European Vaccine Initiative; University of Oxford; Malaria Research and Training Center, Bamako, Mali Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials